Article
Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS).
Journal of inherited metabolic disease - 1 Jun 2007
Haas D, Garbade S F, Vohwinkel C, Muschol N, Trefz F K, Penzien J M, Zschocke J, Hoffmann G F, Burgard P
Abstract excerpt
Smith-Lemli-Opitz syndrome (SLOS) is a malformation syndrome caused by deficiency of 7-dehydrocholesterol reductase catalysing the last step of cholesterol biosynthesis. This results in an accumulation of 7- and 8-dehydrocholesterol (7 + 8-DHC) and, in most patients, a deficiency of cholesterol. Current therapy consists of dietary cholesterol supplementation, which raises plasma cholesterol levels, but clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
